N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide

C184H359N31O10 — CID 165037083

IUPACN-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide
SMILESCC(C)(C)CN1CCC2(CCN(C(=O)NC(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)C1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)CC1.CC(C)(C)NC(=O)N1CCC2(CC1)CCN(C(C)(C)C)CC2.CC(C)(C)NC(=O)N1CCN(CC2CN(C(C)(C)C)C2)CC1
InChIInChI=1S/2C20H39N3O.2C19H37N3O.4C18H35N3O.C17H34N4O.C17H33N3O/c2*1-19(2,3)21-18(24)17-9-11-22(12-10-17)15-16-7-13-23(14-8-16)20(4,5)6;2*1-18(2,3)20-17(23)16-9-10-21(14-16)13-15-7-11-22(12-8-15)19(4,5)6;1-16(2,3)19-15(22)20-11-7-18(8-12-20)9-13-21(14-10-18)17(4,5)6;1-16(2,3)13-20-10-7-18(14-20)8-11-21(12-9-18)15(22)19-17(4,5)6;2*1-17(2,3)19-16(22)15-7-9-20(10-8-15)11-14-12-21(13-14)18(4,5)6;1-16(2,3)18-15(22)20-9-7-19(8-10-20)11-14-12-21(13-14)17(4,5)6;1-16(2,3)18-15(21)14-7-8-19(12-14)9-13-10-20(11-13)17(4,5)6/h2*16-17H,7-15H2,1-6H3,(H,21,24);2*15-16H,7-14H2,1-6H3,(H,20,23);2*7-14H2,1-6H3,(H,19,22);2*14-15H,7-13H2,1-6H3,(H,19,22);14H,7-13H2,1-6H3,(H,18,22);13-14H,7-12H2,1-6H3,(H,18,21)
InChIKeyNNWNTNLQWUJMAP-UHFFFAOYSA-N
MW3166.10 g/mol
LogP27.00
Rot. Bonds24

About N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide

N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide (PubChem CID 165037083) has the molecular formula C184H359N31O10 and a molecular weight of 3166.10 g/mol. Its IUPAC name is N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide.

Molecular Properties

Compound NameN-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide
PubChem CID165037083
Molecular FormulaC184H359N31O10
Molecular Weight3166.10 g/mol
Exact Mass3163.85
IUPAC NameN-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide
SMILESCC(C)(C)CN1CCC2(CCN(C(=O)NC(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)C1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)CC1.CC(C)(C)NC(=O)N1CCC2(CC1)CCN(C(C)(C)C)CC2.CC(C)(C)NC(=O)N1CCN(CC2CN(C(C)(C)C)C2)CC1
InChIInChI=1S/2C20H39N3O.2C19H37N3O.4C18H35N3O.C17H34N4O.C17H33N3O/c2*1-19(2,3)21-18(24)17-9-11-22(12-10-17)15-16-7-13-23(14-8-16)20(4,5)6;2*1-18(2,3)20-17(23)16-9-10-21(14-16)13-15-7-11-22(12-8-15)19(4,5)6;1-16(2,3)19-15(22)20-11-7-18(8-12-20)9-13-21(14-10-18)17(4,5)6;1-16(2,3)13-20-10-7-18(14-20)8-11-21(12-9-18)15(22)19-17(4,5)6;2*1-17(2,3)19-16(22)15-7-9-20(10-8-15)11-14-12-21(13-14)18(4,5)6;1-16(2,3)18-15(22)20-9-7-19(8-10-20)11-14-12-21(13-14)17(4,5)6;1-16(2,3)18-15(21)14-7-8-19(12-14)9-13-10-20(11-13)17(4,5)6/h2*16-17H,7-15H2,1-6H3,(H,21,24);2*15-16H,7-14H2,1-6H3,(H,20,23);2*7-14H2,1-6H3,(H,19,22);2*14-15H,7-13H2,1-6H3,(H,19,22);14H,7-13H2,1-6H3,(H,18,22);13-14H,7-12H2,1-6H3,(H,18,21)
InChIKeyNNWNTNLQWUJMAP-UHFFFAOYSA-N
XLogP27.00
TPSA359.04 Ų
H-Bond Donors10
H-Bond Acceptors28
Rotatable Bonds24
Heavy Atoms225
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003166.10
LogP ≤ 527.00
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1028

Analyze N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N,2-dimethyl-4-(2-methylpropanoyl)-N-propan-2-ylpiperazine-1-carboxamide;N,3-dimethyl-4-(2-methylpropanoyl)-N-propan-2-ylpiperazine-1-carboxamide;N-methyl-4-(2-methylpropanoyl)-3-oxo-N-propan-2-ylpiperazine-1-carboxamide;N-methyl-2-(2-methylpropanoyl)-N-propan-2-yl-2-azaspiro[3.3]heptane-6-carboxamide;N-methyl-4-(2-methylpropanoyl)-N-propan-2-ylpiperazine-1-carboxamide;8-(2-methylpropanoyl)-2-propan-2-yl-2,8-diazaspiro[4.5]decan-1-one;9-(2-methylpropanoyl)-2-propan-2-yl-2,9-diazaspiro[4.5]decan-1-one;2-(2-methylpropanoyl)-6-propan-2-yl-2,6-diazaspiro[3.5]nonan-5-one;7-(2-methylpropyl)-2-propan-2-yl-2,7-diazaspiro[4.4]nonan-1-one
CID 159840521
N,3-dimethyl-N-propan-2-ylbutanamide;2,8-di(propan-2-yl)-2,8-diazaspiro[4.5]decan-1-one;2,7-di(propan-2-yl)-2,7-diazaspiro[4.4]nonan-1-one;2,6-di(propan-2-yl)-2,6-diazaspiro[3.4]octan-5-one;1,3-di(propan-2-yl)imidazolidin-2-one;1,4-di(propan-2-yl)piperazin-2-one;N-ethyl-N,1-di(propan-2-yl)azetidine-3-carboxamide;N-methyl-N,2-di(propan-2-yl)-2-azabicyclo[2.1.1]hexane-4-carboxamide;N-methyl-N,1-di(propan-2-yl)azetidine-3-carboxamide;N-methyl-N,4-di(propan-2-yl)piperazine-1-carboxamide;N-methyl-N,1-di(propan-2-yl)piperidine-3-carboxamide;N-methyl-N,1-di(propan-2-yl)piperidine-4-carboxamide;N-methyl-N,1-di(propan-2-yl)pyrrolidine-3-carboxamide;3-[methyl(propan-2-yl)amino]-1-propan-2-ylpyrrolidin-2-one;N-methyl-N-propan-2-yl-2-(propan-2-ylamino)acetamide;1-propan-2-yl-3-(propan-2-ylamino)pyrrolidin-2-one
CID 160598525
N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide
CID 165026500

Frequently Asked Questions

What is the IUPAC name of N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide?
The IUPAC name of N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide (CID 165037083) is N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide.
What is the SMILES notation for N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide?
The canonical SMILES for N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide is CC(C)(C)CN1CCC2(CCN(C(=O)NC(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)C1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)CC1.CC(C)(C)NC(=O)N1CCC2(CC1)CCN(C(C)(C)C)CC2.CC(C)(C)NC(=O)N1CCN(CC2CN(C(C)(C)C)C2)CC1.
What is the InChIKey of N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide?
The InChIKey is NNWNTNLQWUJMAP-UHFFFAOYSA-N. The full InChI is InChI=1S/2C20H39N3O.2C19H37N3O.4C18H35N3O.C17H34N4O.C17H33N3O/c2*1-19(2,3)21-18(24)17-9-11-22(12-10-17)15-16-7-13-23(14-8-16)20(4,5)6;2*1-18(2,3)20-17(23)16-9-10-21(14-16)13-15-7-11-22(12-8-15)19(4,5)6;1-16(2,3)19-15(22)20-11-7-18(8-12-20)9-13-21(14-10-18)17(4,5)6;1-16(2,3)13-20-10-7-18(14-20)8-11-21(12-9-18)15(22)19-17(4,5)6;2*1-17(2,3)19-16(22)15-7-9-20(10-8-15)11-14-12-21(13-14)18(4,5)6;1-16(2,3)18-15(22)20-9-7-19(8-10-20)11-14-12-21(13-14)17(4,5)6;1-16(2,3)18-15(21)14-7-8-19(12-14)9-13-10-20(11-13)17(4,5)6/h2*16-17H,7-15H2,1-6H3,(H,21,24);2*15-16H,7-14H2,1-6H3,(H,20,23);2*7-14H2,1-6H3,(H,19,22);2*14-15H,7-13H2,1-6H3,(H,19,22);14H,7-13H2,1-6H3,(H,18,22);13-14H,7-12H2,1-6H3,(H,18,21).
What are the key properties of N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide?
N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide has a molecular weight of 3166.10 g/mol, XLogP of 27.00, 24 rotatable bonds, 10 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide);N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide);bis(N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide);N-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[4.5]decane-8-carboxamide;N,3-ditert-butyl-3,9-diazaspiro[5.5]undecane-9-carboxamide is sourced from PubChem (CID 165037083), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).